People · Operator
Named in public records as an officer, director or promoter · active 2019–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Entera Bio Ltd. | — | Biotechnology | Series A | $22.2M | $44.9M | 2019 |
| IceCure Medical Ltd. | — | Biotechnology | Seed | $8.0M | $7.4M | 2026 |
Yonatan Malca at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yonatan Malca on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ron Mayron | 2 | 6 |
| Adam Gridley | 1 | 4 |
| Faith Charles | 1 | 4 |
| Gerald Ostrov | 1 | 3 |
| Yaacov Goldman | 1 | 3 |
| Sean Ellis | 1 | 3 |
| Doron Cohen | 1 | 3 |
| Miranda Toledano | 1 | 3 |
| Doron Birger | 1 | 3 |
| Sharon Levita | 1 | 2 |
| Gerald Lieberman | 1 | 2 |
| Zeev Bronfeld | 1 | 2 |
| Adi Goldin | 1 | 2 |
| Vincent Chun Hung Chan | 1 | 2 |
| Eyal Shamir | 1 | 2 |
| Shay Levav | 1 | 2 |
| Yang Huang | 1 | 2 |
| Elka Nir | 1 | 2 |
| Tlalit Bussi Tel-Tzure | 1 | 2 |
| Merav Nir Dotan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.